Sponsors (2)
The bill strengthens transparency and congressional oversight of financial conflicts (especially royalty disclosures) for advisory members, contractors, and grantees—improving accountability—but does so at the cost of increased privacy intrusion, administrative burdens, and compliance costs that could deter experts and divert agency resources.
Scientists, federal employees, and the public will gain substantially more transparency into potential conflicts because advisory‑committee members must publicly disclose financial interests and agencies/GAO must publish royalty and disclosure records.
Taxpayers and policymakers will have clearer visibility into monetary ties from inventions because the bill requires disclosure of royalty sources and amounts, helping detect financial influences on research and contracting.
Members of Congress and oversight committees will get immediate, detailed notification and justification for ethics waivers/exemptions, strengthening congressional oversight of conflicts of interest.
Scientists, federal employees, and their families may face significant privacy intrusion and administrative burden from required public disclosures and distribution of financial reports, which could discourage participation and impose personal risks.
Expanded disclosure and waiver reporting may deter qualified experts from serving on advisory committees, reducing the effectiveness and expertise available to public‑health and policy bodies.
Government contractors and grantees will face increased compliance costs and administrative burdens to track and disclose royalty payments, potentially raising costs and narrowing the pool of applicants.
Based on analysis of 4 sections of legislative text.
Requires covered public-health advisory members to file financial disclosures, adds royalty-payment checks to contractor/grantee COI reviews, and mandates agency reporting to Congress.
Introduced March 5, 2025 by Rand Paul · Last progress March 5, 2025
Expands federal financial disclosure and conflict-of-interest rules to cover certain advisory committee members who influenced public health policy and to capture royalty payments when agencies review contractor or grantee conflicts. It requires GAO to list covered advisory committees, directs ethics offices to notify Congress when waivers or exemptions are granted, and forces agencies to report annually to Congress on potential royalty-related conflicts and mitigation steps. A five-year sunset narrows some successor language and removes an annual GAO-listing requirement after that period.